Hospital das Clínicas Caracas, Unidad de Exploraciones Digestivas, Caracas, Venezuela.
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Gastrointest Endosc. 2019 Apr;89(4):671-679.e1. doi: 10.1016/j.gie.2018.11.034. Epub 2018 Dec 6.
Endoscopy has evolved to become first-line therapy for the treatment of post-bariatric leaks; however, many sessions are often required with variable success rates. Due to these limitations, the use of the cardiac septal defect occluder (CSDO) has recently been reported in this population.
The study population was a multicenter retrospective series of patients with post-bariatric surgical leaks who underwent treatment with CSDO placement. Data on the type of surgery, previous treatment details, fistula dimensions, success rate, and adverse events were collected. Leaks were grouped according to the International Sleeve Gastrectomy Expert Panel Consensus. Outcomes included technical and clinical success and safety of the CSDO. Regression analysis was performed to determine the predictors of response.
Forty-three patients with leaks were included (31 sleeve gastrectomy and 12 Roux-en-Y gastric bypass). They were divided into acute (n = 3), early (n = 5), late (n = 23), and chronic (n = 12). Forty patients had failed previous endoscopic treatment and 3 patients had CSDO as the primary treatment. Median follow-up was 34 weeks. Technical success was achieved in all patients and clinical success in 39 patients (90.7%). All chronic, late, and early leaks were successfully closed, except one undrained late leak. The 5 patients with early leaks had an initial satisfactory response, but within 30 days, drainage recurred. The CSDOs were removed and replaced with larger-diameter devices leading to permanent defect closure. Acute leaks were not successfully closed in all 3 patients. Regression analysis showed that chronicity and previous treatment were associated with fistula closure; success rates for late/chronic leaks versus acute/early leaks were 97.1% and 62.5%, respectively (P = .0023).
This observational study found that the CSDO had a high efficacy rate in patients with non-acute leaks, with no adverse events. All early, late, and chronic leaks were successfully closed, except for one undrained late leak. However, early leaks required a second placement of a larger CSDO in all cases. These results suggest that the CSDO should be considered for non-acute fistula and that traditional closure methods are likely preferred in the acute and early settings.
内镜治疗已成为治疗减重手术后吻合口漏的一线治疗方法;然而,许多患者往往需要多次治疗,且成功率不一。由于这些局限性,最近有报道称在这类人群中使用心脏间隔缺损封堵器(CSDO)。
该研究为多中心回顾性系列病例研究,纳入了接受 CSDO 置入术治疗的减重手术后吻合口漏患者。收集了手术类型、既往治疗细节、瘘管尺寸、成功率和不良事件等数据。根据国际袖状胃切除术专家小组共识,将漏口分为急性(n=3)、早期(n=5)、晚期(n=23)和慢性(n=12)。其中 40 例患者曾行内镜治疗失败,3 例患者为初次 CSDO 治疗。中位随访时间为 34 周。所有患者均达到技术成功,39 例患者达到临床成功(90.7%)。所有慢性、晚期和早期漏口均成功闭合,除 1 例未引流的晚期漏口外。5 例早期漏口患者最初治疗反应满意,但在 30 天内引流再次出现。CSDO 被取出并更换为更大直径的装置,导致瘘口永久性闭合。所有 3 例急性漏口均未成功闭合。回归分析显示,慢性和既往治疗与瘘口闭合相关;晚期/慢性漏口与急性/早期漏口的闭合率分别为 97.1%和 62.5%(P=0.0023)。
本观察性研究发现,CSDO 对非急性漏口患者具有较高的疗效,无不良事件发生。所有早期、晚期和慢性漏口均成功闭合,除 1 例未引流的晚期漏口外。然而,所有早期漏口均需要再次放置更大直径的 CSDO。这些结果表明,对于非急性瘘口,应考虑使用 CSDO,而在急性和早期阶段,传统的闭合方法可能更为优选。